Atlas Trials

A Study to Evaluate the Safety and Tolerability of AZD7442 in Healthy Chinese Adults

Clinical trial NCT05437289 · COMPLETED

Trial details

NCT number
NCT05437289
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Coronavirus Disease 2019 (COVID-19)Healthy Volunteer
Start date
2021-10-09
Primary completion
2021-11-27
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.